KYC is one time exercise with a SEBI registered intermediary while dealing in securities markets (Broker/ DP/ Mutual Fund etc.). | No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |   Prevent unauthorized transactions in your account – Update your mobile numbers / email ids with your stock brokers. Receive information of your transactions directly from exchange on your mobile / email at the EOD | Filing Complaint on SCORES - QUICK & EASY a) Register on SCORES b) Mandatory details for filing complaints on SCORE - Name, PAN, Email, Address and Mob. no. c) Benefits - speedy redressal & Effective communication   |   BSE Prices delayed by 5 minutes...<< Prices as on Jul 29, 2026 - 2:49PM >>  ABB India 7358.75  [ 1.56% ]  ACC 1374.4  [ 2.43% ]  Ambuja Cements 436.1  [ 2.30% ]  Asian Paints 2823.45  [ 3.17% ]  Axis Bank 1234.85  [ 0.94% ]  Bajaj Auto 11320.7  [ -0.45% ]  Bank of Baroda 244.35  [ 2.13% ]  Bharti Airtel 1954.4  [ 2.74% ]  Bharat Heavy 405.65  [ 0.01% ]  Bharat Petroleum 317.85  [ -0.67% ]  Britannia Industries 5526.7  [ 0.83% ]  Cipla 1477  [ 2.24% ]  Coal India 411  [ 0.22% ]  Colgate Palm 2162.75  [ 1.28% ]  Dabur India 433.15  [ 1.99% ]  DLF 669.65  [ 1.00% ]  Dr. Reddy's Lab. 1141.6  [ 0.52% ]  GAIL (India) 175.65  [ 0.31% ]  Grasim Industries 3121.5  [ 0.21% ]  HCL Technologies 1343.4  [ 1.84% ]  HDFC Bank 749.45  [ 1.90% ]  Hero MotoCorp 5155  [ 0.08% ]  Hindustan Unilever 2112.2  [ 4.40% ]  Hindalco Industries 960.2  [ 2.51% ]  ICICI Bank 1439.4  [ 0.81% ]  Indian Hotels Co. 739.5  [ 0.67% ]  IndusInd Bank 1012.8  [ 2.02% ]  Infosys 1158.15  [ 4.74% ]  ITC 286.9  [ 0.83% ]  Jindal Steel 1090  [ 3.39% ]  Kotak Mahindra Bank 392.1  [ 1.74% ]  L&T 3938.65  [ 2.76% ]  Lupin 2452  [ 2.39% ]  Mahi. & Mahi 3224.75  [ -1.46% ]  Maruti Suzuki India 13922.5  [ 0.86% ]  MTNL 27.17  [ 1.53% ]  Nestle India 1503.95  [ 0.62% ]  NIIT 98.2  [ 2.94% ]  NMDC 86.02  [ 2.49% ]  NTPC 343.55  [ -0.07% ]  ONGC 239.45  [ 0.27% ]  Punj. NationlBak 111.35  [ -0.27% ]  Power Grid Corpn. 282.95  [ -0.82% ]  Reliance Industries 1278.4  [ 0.83% ]  SBI 1015.25  [ 0.24% ]  Vedanta 263.15  [ 1.45% ]  Shipping Corpn. 279  [ 0.07% ]  Sun Pharmaceutical 1977.9  [ 0.04% ]  Tata Chemicals 683.05  [ 1.18% ]  Tata Consumer 1098.3  [ 1.48% ]  Tata Motors Passenge 328.5  [ 1.34% ]  Tata Steel 187.25  [ 2.49% ]  Tata Power Co. 376.9  [ 1.52% ]  Tata Consult. Serv. 2452  [ 2.26% ]  Tech Mahindra 1647.75  [ 0.77% ]  UltraTech Cement 11999.15  [ 0.25% ]  United Spirits 1507.9  [ -0.08% ]  Wipro 184  [ 1.60% ]  Zee Entertainment 107.65  [ 0.00% ]  

Company Information

Indian Indices

  • Loading....

Global Indices

  • Loading....

Forex

  • Loading....

MEDICAMEN BIOTECH LTD.

29 July 2026 | 02:39

Industry >> Pharmaceuticals

Select Another Company

ISIN No INE646B01010 BSE Code / NSE Code 531146 / MEDICAMEQ Book Value (Rs.) 203.14 Face Value 10.00
Bookclosure 19/09/2025 52Week High 448 EPS 7.11 P/E 33.64
Market Cap. 324.26 Cr. 52Week Low 212 P/BV / Div Yield (%) 1.18 / 0.00 Market Lot 1.00
Security Type Other

History of Company

The company history sections lists out major chronological events that happened to the company.
MBL was incorporated as a public limited company under the Companies Act, 1956, on December 22, 1993. The certificate of commencement of business was obtained on January 31, 1994. The company has jointly been promoted by Mr.V.Kumar, Mr.Bal Kishan Gupta, Mr.Lakhvinder Singh Arora and Mr.Ranjit Singh. MBL is engaged in marketing of various drugs in the domestic and export markets. Company is procuring drugs from various reputed manufactures viz. Hoechst, Cadila, Hindustan Ciba, Purepharma, Oboi Labs etc. and exporting to countries like Germany, Russia, Holland, CIS (Confederation of Independent States) etc. part from domestic ethical and institutional sales. MBL has obtained permission for production of tablets, capsules and liquid orals under loan licence basis from Delhi Drug Control Authority and Madhya Pardesh Drug Control Authority on Welbeck Pharmaceutical Private Limited, New Delhi and Pure Pharma Private Limited, Indore respectively. 2010 -The Company has recommended a final dividend of Rs. 0.75 per equity share (being 7.5% on the face value of Rs. 10 per share) -The Company appointed Mr. B.K.Gupta as Managing Director. 2011 -The Company gets ANVISA.Brazil approval for Non Beta Lactum solid Tablets and Coated tablets manufactured at its Plant situated at SP 1192,A & B, Phase 4, Bhiwadi - 301019, Rajasthan. 2013 -Ms. Harshita Sharma has been appointed as Additional Director of the company. 2016 -Shivalik Rasayan Ltd take controlling stake of Medicamen Biotech Ltd. 2019 -FABD(Philippines), CECMED(Cuba)-Bhiwadi FDF Plant. 2020 -Global API Facility started Dahej API Plant. 2021 -Operations started Haridwar formulation Unit II(FDF). 2023 -Medicamen Biotech Gains On Successful Anda Filing For Bortezomib Injections.

2024
-Medicamen Biotech's Bhiwadi Manufacturing Facility Secures EU GMP Approval from Greece.
-Medicamen Biotech's Sterile injectable Facility Received USFDA Approval.